<DOC>
	<DOCNO>NCT02503982</DOCNO>
	<brief_summary>Valganciclovir extensively use cytomegalovirus ( CMV ) infection treatment prophylaxis solid organ transplantation ( SOT ) . VGC dose problematic child . valganciclovir variable absorption renally excrete . Area Under Curve ( AUC ) ( 0-24 ) 40-60 mcg∙h/L predictive pharmacokinetic parameter efficacy safety . Dosing base manufacturer recommendation supra-therapeutic case . A published dosing algorithm result AUC range . Objective : To prospectively validate Valganciclovir administration dose regimen compare dose algorithm . Methods : Children SOT Schneider Children 's Medical Center , large tertiary pediatric center Israel , prospectively study , start Dec 2014 . The dose regimen derive Seattle Children 's Hospital guideline ; 14-16 mg/kg/dose . For impaired renal function , stratify dose reduction use . Blood withdrawn steady state : 2 , 5 10 hour post dose . Drug level analyze high pressure liquid chromatography ( HPLC ) .</brief_summary>
	<brief_title>Valganciclovir Dosing Pediatric Solid Organ Transplant Recipients</brief_title>
	<detailed_description>Valganciclovir novel drug use extensively prophylactic , preemptive treatment agent cytomegalovirus ( CMV ) infection solid organ transplantation ( SOT ) . It valine ester prodrug Ganciclovir , bioavailability approximately 60 % , 10-fold high oral ganciclovir . Based correlation Pharmacokinetic ( PK ) VGC clinical efficacy find adult study , AUC ( 0-24 ) approximately 40-60 mcg∙h/mL describe predictive PK parameter efficacy . Considering mechanism action Valganciclovir , relationships exposure-efficacy exposure-safety expect similar child adult . In 2009 , new dose algorithm incorporate body surface area ( BSA ) renal function introduce manufacturer infant young child : Dose ( mg ) =7 × BSA × CrCl Very study evaluate dose infant young child . In 2010 FDA publish safety alert confirm excessively high dosage calculate dose algorithm child low body weight , low body surface area , normal serum creatinine . This type patient routinely observe clinical trial use derive confirm pediatric dose . As body weight decrease and/or Creatinine Clearance ( CrCl ) increase excessively high dos calculate . There unproportional variability dos calculate algorithm infant young child normal renal function . Doses reach high 4 fold high weight-based common dosing . Objective : 1 . To prospectively validate dose regimen Valganciclovir administration 2. compare dose algorithm . Methods : This prospective study pediatric SOT recipient treat oral valganciclovir . The common practice dose Schneider Children 's Medical Center dose guideline valganciclovir 17 mg/kg daily prophylaxis , stratify dose reduction impair renal function show table . Max dose 900 mg . Measurement valganciclovir level After three day consistent oral dose ensure steady-state concentration , drug level measure 2 , 5 10 h follow administration dose , analyze pharmacologic laboratory `` Asaf HaRofeh Medical Center '' use standard HPLC , low limit detection 0.5 mcg/mL coefficient variation &lt; 10 % . AUCs calculate use trapezoidal method .</detailed_description>
	<mesh_term>Valganciclovir</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<criteria>1. child adolescents 018 year old 2 . Solid Organ Transplantation admit transplantation 3 . Treatment prophylactic Valganciclovir 4 . Glomerular Filtration Rate ( GFR ) &gt; = 60 mL/min/1.73 m2 1 . Treatment ganciclovir IV 2 . Glomerular Filtration Rate ( GFR ) &lt; 60 mL/min/1.73 m2 3 . Imipenem treatment 4 . Cluster organ transplant</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>